Anticancer Activity and Mechanisms of Action of New Chimeric EGFR/HDAC-Inhibitors

New chimeric inhibitors targeting the epidermal growth factor (EGFR) and histone deacetylases (HDACs) were synthesized and tested for antineoplastic efficiency in solid cancer (prostate and hepatocellular carcinoma) and leukemia/lymphoma cell models. The most promising compounds, 3BrQuin-SAHA and 3C...

Descripción completa

Detalles Bibliográficos
Autores principales: Goehringer, Nils, Biersack, Bernhard, Peng, Yayi, Schobert, Rainer, Herling, Marco, Ma, Andi, Nitzsche, Bianca, Höpfner, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395095/
https://www.ncbi.nlm.nih.gov/pubmed/34445133
http://dx.doi.org/10.3390/ijms22168432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395095/
https://www.ncbi.nlm.nih.gov/pubmed/34445133
http://dx.doi.org/10.3390/ijms22168432

Ejemplares similares